Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
CURI vs GAIA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CURI Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)
CURI Overall Winner
6-Pillar Tally: CURI 5 – 1 GAIA
Matrix Metrics: CURI 9 – 1 GAIA
As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Gaia, Inc. (GAIA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CURI carries a Unified Composite Score of 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin), whereas GAIA carries 48.5/100 (HOLD) at $1.22 (138.9x Forward P/E, -8.7% operating margin).
- Technical & Structure Timing Caution: CURI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5); meanwhile GAIA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CURI vs GAIA
CURI
Head-to-Head Winner
CuriosityStream Inc. Class A Common Stock
$2.54
-2.68% 1D
Market Cap
$154.9M
TTM Revenue
$78M
Forward P/E
6.9x
Beta / 30D Vol
1.36β · 99% Vol
Unified Composite Score
52.8
HOLD
Tech 62.0
Fund 53.0
Flow 58.0
Mom 50.0
Weinstein Technical Phase
Markdown · Sell / avoid
GAIA
Gaia, Inc. Class A Common Stock
$1.22
-3.94% 1D
Market Cap
$32.3M
TTM Revenue
$95M
Forward P/E
138.9x
Beta / 30D Vol
0.50β · 66% Vol
Unified Composite Score
48.5
HOLD
Tech 63.0
Fund 73.0
Flow 64.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (CURI 5 – 1 GAIA)
1. Valuation Multiples
CURI
Forward P/E
6.9x
138.9x
Trailing P/E
17.4x
138.9x
PEG Ratio
N/M
1.23x
EV / Revenue
N/M
0.4x
2. Growth & Scale
CURI
Revenue Growth (YoY)
+12.9%
-11.8%
Earnings Growth (YoY)
N/A
-87.8%
TTM Revenue (USD)
$78M
$95M
Market Cap
$154.9M
$32.3M
3. Profitability & Quality
CURI
Gross Margin
60.2%
86.1%
Operating Margin
10.1%
-8.7%
Net Profit Margin
11.0%
-8.2%
Return on Equity (ROE)
19.3%
-8.7%
4. Balance Sheet & Cash Flow
CURI
Cash Generation (TTM)
$25M EBITDA
-$776,000
Cash Flow Margin
31.9% EBITDA Mgn
-0.8%
Net Cash / Leverage
$631M Net Cash
$1.5M Net Debt (0.17x D/E)
Dividend Yield
12.02%
None (0.00%)
5. Options & Positioning
GAIA
Options Structure Phase
BREAKDOWN
UNCLASSIFIED
Current IV / %ile
67.6% (3rd %ile)
146.8% (100th %ile)
Put/Call OI Skew
0.93x (Balanced)
N/A
OBV Trend / Tech Phase
ACCUMULATION · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
CURI
OpEx & R&D Intensity
50.1% of Rev ($39M)
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Broadcasting Operator
Entertainment Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CURI (9) vs GAIA (1)| Institutional Metric | CURI | GAIA | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $154.9M | $32.3M | CURI | |
| Trailing P/E Ratio | 17.4x | 138.9x | CURI | |
| Forward P/E Ratio | 6.9x | 138.9x | CURI | |
| Revenue Growth (YoY) | +12.9% | -11.8% | CURI | |
| Operating Margin (TTM) | 10.1% | -8.7% | CURI | |
| Net Profit Margin | 11.0% | -8.2% | CURI | |
| Return on Equity (ROE) | 19.3% | -8.7% | CURI | |
| 52-Week Range Position | 9% ($2–$5) | 2% ($1–$4) | CURI | |
| Beta / 30D Volatility | 1.36β · 99% Vol | 0.50β · 66% Vol | GAIA | |
| Unified Institutional Score | 52.8 / 100 (HOLD) | 48.5 / 100 (HOLD) | CURI | |
| Trailing 12M Revenue (USD) | $78M | $95M | Scale | |
| Gross Profit Margin (TTM) | 60.2% | 86.1% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · N/M EV/Rev | 1.23x PEG · 0.4x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $25M EBITDA ($631M Net Cash) | -$776,000 ($1.5M Net Debt (0.17x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
CURI +2.27 pp
3M Horizon
CURI +6.45 pp
6M Horizon
CURI +50.61 pp
1Y Horizon
CURI +24.81 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CURI Revenue | GAIA Revenue | CURI Op. Margin | GAIA Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | N/A | $40M | N/A | -86.7% | GAIA |
| FY2019 | $20M | $50M | -247.4% | -31.9% | GAIA |
| FY2020 | $40M | $70M | -97.9% | -6.9% | GAIA |
| FY2021 | $70M | $80M | -73.6% | 2.5% | GAIA |
| FY2022 | $80M | $80M | -70.8% | -0.3% | GAIA |
| FY2023 | $60M | $80M | -78.2% | -5.7% | GAIA |
| FY2024 | $50M | $90M | -26.1% | -6.4% | GAIA |
| FY2025 | $70M | $100M | -10.2% | -5.2% | GAIA |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CURI
BREAKDOWN
Current IV
67.6%
IV Percentile
3rd %ile
Put/Call OI Skew
0.93x (Balanced)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact CURI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
GAIA
UNCLASSIFIED
Current IV
146.8%
IV Percentile
100th %ile
Put/Call OI Skew
N/A
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact GAIA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CURI Moat Profile
Scale & Operating Efficiency Moat
Broadcasting Operator
OpEx & R&D Reinvestment
50.1% of Rev ($39M)
90D Engineering Disclosures
0 Published
GAIA Moat Profile
Cyclical / Execution-Driven Positioning
Entertainment Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ CURI vs GAIA Key Questions & Quantitative Answers
As of Nov 20, 2026, CuriosityStream Inc. (CURI) is the stronger overall head-to-head candidate over Gaia, Inc. (GAIA) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CURI carries a Unified Composite Score of 52.8/100 (HOLD) at $2.54 (6.9x Forward P/E, 10.1% operating margin), whereas GAIA carries 48.5/100 (HOLD) at $1.22 (138.9x Forward P/E, -8.7% operating margin). Technical & Structure Timing Caution: CURI is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 43.5); meanwhile GAIA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CURI leads the Growth & Scale pillar: CURI posts +12.9% YoY revenue growth and N/A YoY earnings growth on $78M TTM revenue (60.2% gross margin, 10.1% operating margin), compared with GAIA at -11.8% YoY revenue growth and -87.8% YoY earnings growth on $95M TTM revenue (86.1% gross margin, -8.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CURI cumulative revenue shifted +250.0% while GAIA shifted +150.0%. In operating R&D and SG&A reinvestment, CURI deploys 50.1% of Rev ($39M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GAIA.
CURI screens cheaper on headline valuation multiples. CURI trades at 6.9x Forward P/E, 17.4x Trailing P/E, N/M PEG, and N/M EV/Revenue (31.9% EBITDA margin), whereas GAIA trades at 138.9x Forward P/E, 138.9x Trailing P/E, 1.23x PEG, and 0.4x EV/Revenue (-0.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CURI (19.3% ROE) versus GAIA (-8.7% ROE) capital efficiency.
In options market volatility and institutional positioning, CURI carries 67.6% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.93x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (1.36β · 99% Vol realized risk). By comparison, GAIA carries 146.8% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 66% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
GAIA vs CURI · Reverse Pair
CURI vs FLGT
· Sector Peer
CURI vs LOB
· Sector Peer
CURI vs MGNI
· Sector Peer
GAIA vs GABC
· Sector Peer
GAIA vs FSTR
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem